Cleared Traditional

K251582 - Redermax Antibacterial Wound Matrix (FDA 510(k) Clearance)

Feb 2026
Decision
255d
Days
-
Risk

K251582 is an FDA 510(k) clearance for the Redermax Antibacterial Wound Matrix. This device is classified as a Dressing, Wound, Drug.

Submitted by Beijing Kreate Medical Co., Ltd. (Beijing, CN). The FDA issued a Cleared decision on February 2, 2026, 255 days after receiving the submission on May 23, 2025.

This device falls under the General & Plastic Surgery FDA review panel.

Submission Details

510(k) Number K251582 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 23, 2025
Decision Date February 02, 2026
Days to Decision 255 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF

Device Classification

Product Code FRO - Dressing, Wound, Drug
Device Class -

Similar Devices - FRO Dressing, Wound, Drug

All 18
MiraChlor Antimicrobial Wound Solution
K252023 · Letus Corporation · Mar 2026
Promogran Prisma™ Collagen Matrix with ORC and Silver
K251999 · Solventum Germany GmbH · Mar 2026
LUOFUCON® Antimicrobial Wound Gel
K252028 · Huizhou Foryou Medical Co., Ltd. · Mar 2026
New Day Skin Spray
K252568 · Silk Holdings, Inc. · Jan 2026
SBC1 Cream
K250890 · Sioxmed, LLC · Jan 2026
LUOFUCON® Skin and Wound Cleanser (Spray, Mist, Squeeze, Bottle.)
K250642 · Huizhou Foryou Medical Devices Co., Ltd. · Nov 2025